Loading...
XNYSPHR
Market cap1.65bUSD
Jan 08, Last price  
28.43USD
1D
5.37%
1Q
38.75%
IPO
18.46%
Name

Phreesia Inc

Chart & Performance

D1W1MN
XNYS:PHR chart
P/E
P/S
4.64
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
96.87%
Rev. gr., 5y
28.96%
Revenues
356m
+26.84%
79,834,00099,888,805124,784,000148,677,000213,233,000280,910,000356,299,000
Net income
-137m
L-22.29%
-18,192,000-15,062,007-20,293,000-27,292,000-118,161,000-176,146,000-136,885,000
CFO
-32m
L-64.07%
-11,142,000-2,129,926826,0002,890,000-74,710,000-90,123,000-32,378,000
Earnings
Mar 12, 2025

Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
IPO date
Jul 18, 2019
Employees
1,576
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑012023‑012022‑012021‑012020‑012019‑012018‑01
Income
Revenues
356,299
26.84%
280,910
31.74%
213,233
43.42%
Cost of revenue
463,291
432,158
308,748
Unusual Expense (Income)
NOPBT
(106,992)
(151,248)
(95,515)
NOPBT Margin
Operating Taxes
1,543
483
182
Tax Rate
NOPAT
(108,535)
(151,731)
(95,697)
Net income
(136,885)
-22.29%
(176,146)
49.07%
(118,161)
332.95%
Dividends
Dividend yield
Proceeds from repurchase of equity
(12,176)
(19,383)
236,818
BB yield
0.88%
0.99%
-15.22%
Debt
Debt current
6,449
6,106
7,102
Long-term debt
14,370
7,431
24,500
Deferred revenue
97
125
65
Other long-term liabilities
2,857
(3,074)
(2,711)
Net debt
(66,701)
(163,146)
(282,210)
Cash flow
Cash from operating activities
(32,378)
(90,123)
(74,710)
CAPEX
(5,806)
(26,203)
(30,805)
Cash from investing activities
(39,670)
(26,203)
(65,228)
Cash from financing activities
(17,115)
(20,406)
234,969
FCF
(96,684)
(140,097)
(110,124)
Balance
Cash
87,520
176,683
313,812
Long term investments
Excess cash
69,705
162,638
303,150
Stockholders' equity
(742,392)
(605,542)
(429,417)
Invested Capital
1,008,778
901,316
857,759
ROIC
ROCE
EV
Common stock shares outstanding
54,561
52,440
49,888
Price
25.48
-32.04%
37.49
20.20%
31.19
-52.23%
Market cap
1,390,226
-29.29%
1,965,978
26.35%
1,556,020
-39.69%
EV
1,323,525
1,802,832
1,273,810
EBITDA
(77,505)
(125,944)
(74,213)
EV/EBITDA
Interest
1,854
1,411
1,163
Interest/NOPBT